← Kiniksa Pharmaceuticals International, plc

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations — — — — — — $183.4m $14.1m ($43.2m) $59.0m
Net Income (Loss) Attributable to Parent ($1.5m) ($64.9m) ($103.2m) ($161.9m) ($161.4m) ($157.9m) $183.4m $14.1m ($43.2m) $59.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest — ($64.9m) ($103.2m) ($161.9m) ($161.4m) ($157.9m) $183.4m $14.1m ($43.2m) $59.0m
Depreciation and amortization — — — — — $2.4m $2.4m $2.3m $1.7m $1.6m
Depreciation — $28k $286k $2.1m $2.4m $1.5m $1.2m $1.1m $448k $196k
Depreciation and amortization expense — — — $2.1m $2.4m $2.4m $2.4m $2.3m $1.7m $1.6m
Net amortization (accretion) of discounts on short-term investments — — ($1.4m) ($3.5m) $123k $664k ($82k) ($1.1m) $441k ($916k)
Amortization Of Securities — — — — — — ($82k) ($1.1m) $441k ($916k)
Depreciation Amortization Depletion — — — — — — $2.4m $2.3m $1.7m $1.6m
Deferred Income Tax Expense (Benefit) — ($197k) ($978k) ($3.2m) $4.4m $11k ($185.5m) ($33.8m) $8.1m $13.0m
Deferred income taxes — ($197k) ($978k) ($3.2m) $4.4m $11k ($185.5m) ($33.8m) $8.1m $13.0m
Deferred Income Tax — — — — — — ($185.5m) ($33.8m) $8.1m $13.0m
Deferred Tax — — — — — — ($185.5m) ($33.8m) $8.1m $13.0m
Share-based Payment Arrangement, Noncash Expense — $897k $5.7m $15.1m $20.9m $25.2m $25.1m $27.1m $30.7m $37.0m
Payment, Tax Withholding, Share-based Payment Arrangement — — — — — — $901k $2.2m $5.0m $7.7m
Share-based Payment Arrangement, Expense — $897k $5.7m $15.1m $20.9m $25.2m $25.1m $27.1m $30.7m $37.0m
Share-based compensation expense $0 $897k $5.7m $15.1m $20.9m $25.2m $25.1m $27.1m $30.7m $37.0m
Gain (Loss) on Disposition of Property Plant Equipment — — ($66k) ($21k) — ($103k) ($33k) ($179k) ($1k) $120k
Income Tax Expense (Benefit) — $2k ($214k) ($2.0m) $5.2m $1.4m ($172.3m) ($30.7m) $7.0m $29.9m
Operating lease liabilities — — — ($1.3m) ($1.7m) ($2.6m) ($3.0m) ($3.3m) ($4.0m) ($3.5m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable — — — — — $3.9m $8.7m $8.6m $20.5m ($26.1m)
Increase (Decrease) in Inventories — — — — — $3.7m $17.9m $9.5m ($4.8m) $28.5m
Increase (Decrease) in Accounts Payable — $1.0m $8.8m ($4.7m) ($5.0m) $1.4m $6.0m $347k ($6.3m) $142k
Proceeds from Stock Options Exercised — — $377k $1.1m $6.6m $5.3m $2.6m $2.9m — —
Debt Securities, Available-for-sale, Realized Gain (Loss) — — — — — — — — $0 $0
General and Administrative Expense — $9.0m $21.6m $35.0m $45.3m — — — — —
Investment Income, Interest — $529k $4.7m $6.0m $1.1m $97k — — $9.0m $11.6m
Operating Expenses — $65.4m $108.2m $170.0m $157.4m — — — — —
Non-cash lease expense — — — $1.2m $1.4m $2.6m $3.0m $3.1m $3.1m $3.7m
Prepaid expenses and other current assets ($4k) ($1.2m) ($4.8m) ($1.0m) ($1.3m) $2.9m ($3.9m) ($7.1m) ($2.7m) ($22.5m)
Accounts receivable, net — — — — — ($3.9m) ($8.7m) ($8.6m) ($20.5m) $26.1m
Inventory — — — — — ($3.7m) ($17.9m) ($9.5m) $4.8m ($28.5m)
Contract asset — — — — — — ($7.7m) $7.7m — —
Other long-term assets — — — — ($5.6m) ($3.3m) $2.7m $4.6m ($9.7m) ($1.2m)
Accounts payable $277k $1.0m $8.8m ($4.7m) ($5.0m) $1.4m $6.0m $347k ($6.3m) $142k
Accrued expenses, accrued collaboration expenses and other current liabilities — $4.1m $9.3m $4.6m $8.8m $10.3m ($3.7m) $16.9m $43.7m $37.5m
Deferred revenue — — — — — — $12.0m $261k $19.6m —
Other long-term liabilities — — — $326k $478k ($535k) $1.6m $19k ($35k) $16.7m
Proceeds from issuance of Class A ordinary shares under incentive award plans and employee share purchase plan — — — $1.1m $6.6m $5.9m $3.4m $3.7m $17.2m $40.8m
Payments in connection with ordinary stock tendered for employee tax obligations — — — — — — ($901k) ($2.2m) ($5.0m) ($7.7m)
Change in right-of-use asset as a result of new, modified, and terminated leases — — — — — $1.6m $2.9m $9.6m $1.6m $3.1m
Additions to property and equipment included in accrued expenses and other liabilities — — $1.3m $222k — — — $54k $153k $83k
Beginning Cash Position — — — — — — $122.5m $122.7m $108.0m $183.6m
Cash Flow From Continuing Financing Activities — — — — — — $2.5m $1.5m $12.3m $33.0m
Cash Flow From Continuing Investing Activities — — — — — — ($8.1m) ($29.6m) $37.7m ($189.0m)
Change In Account Payable — — — — — — $6.0m $347k ($6.3m) $142k
Change In Accrued Expense — — — — — — ($3.7m) $16.9m $43.7m $37.5m
Change In Inventory — — — — — — ($17.9m) ($9.5m) $4.8m ($28.5m)
Change In Other Current Assets — — — — — — $2.7m $4.6m ($9.7m) ($1.2m)
Change In Other Current Liabilities — — — — — — ($1.4m) ($3.2m) ($4.0m) $13.2m
Change In Other Working Capital — — — — — — $12.0m $261k $19.6m —
Change In Payable — — — — — — $6.0m $347k ($6.3m) $142k
Change In Payables And Accrued Expense — — — — — — $2.3m $17.3m $37.4m $37.6m
Change In Prepaid Assets — — — — — — ($3.9m) ($7.1m) ($2.7m) ($22.5m)
Change In Receivables — — — — — — ($16.3m) ($950k) ($20.5m) $26.1m
Change In Working Capital — — — — — — ($22.6m) $1.4m $24.8m $24.8m
Changes In Account Receivables — — — — — — ($8.7m) ($8.6m) ($20.5m) $26.1m
Changes In Cash — — — — — — $245k ($14.8m) $75.6m ($18.0m)
End Cash Position — — — — — — $122.7m $108.0m $183.6m $165.6m
Financing Cash Flow — — — — — — $2.5m $1.5m $12.3m $33.0m
Free Cash Flow — — — — — — $5.7m $13.2m $25.4m $136.4m
Gain Loss On Sale Of PPE — — — — — — $33k $179k ($24k) ($120k)
Investing Cash Flow — — — — — — ($8.1m) ($29.6m) $37.7m ($189.0m)
Issuance Of Capital Stock — — — — — $0 $3.4m — — —
Net Intangibles Purchase And Sale — — — — — ($20.0m) $0 $0 — —
Net PPE Purchase And Sale — — — — — — ($14k) ($130k) ($252k) ($1.6m)
Operating Gains Losses — — — — — — $33k $179k ($24k) ($120k)
Other Non Cash Items — — — — — — $3.0m $3.1m $3.1m $3.7m
Proceeds From Stock Option Exercised — — — — — — $3.4m $3.7m $17.2m $40.8m
Purchase Of Intangibles — — — — — ($20.0m) $0 $0 — —
Purchase Of PPE — — $5.3m $3.2m $283k $415k ($105k) ($130k) ($277k) ($1.6m)
Repurchase Of Capital Stock — — — — — — ($901k) ($2.2m) ($5.0m) ($7.7m)
Sale Of PPE — — — — — — $91k $0 $25k $0
Stock Based Compensation — — — — — — $25.1m $27.1m $30.7m $37.0m
Net Cash Provided by (Used in) Operating Activities ($882k) ($50.2m) ($81.0m) ($158.4m) ($136.5m) ($126.3m) $5.8m $13.3m $25.7m $138.0m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment — $69k $5.3m $3.2m $283k $415k $105k $130k $277k $1.6m
Purchases of short-term investments — — ($402.0m) ($488.8m) ($430.2m) ($157.2m) ($135.9m) ($204.9m) ($202.0m) ($386.9m)
Net Investment Purchase And Sale — — — — — — ($8.1m) ($29.4m) $37.9m ($187.4m)
Purchase Of Investment — — — — — — ($135.9m) ($204.9m) ($202.0m) ($386.9m)
Proceeds from the maturities of short-term investments — — $168.1m $541.2m $407.1m $306.3m $127.8m $175.5m $239.9m $199.5m
Sale Of Investment — — — — — — $127.8m $175.5m $239.9m $199.5m
Net Cash Provided by (Used in) Investing Activities $168k ($69k) ($239.2m) $49.2m ($23.4m) $128.6m ($8.1m) ($29.6m) $37.7m ($189.0m)
Cash flows from financing activities:
Common Stock Issuance — — — — — $0 $3.4m — — —
Net Common Stock Issuance — — — — — — ($901k) ($2.2m) ($5.0m) ($7.7m)
Payments of Ordinary Dividends, Common Stock — $0 $0 — — — — — — —
Common Stock Payments — — — — — — ($901k) ($2.2m) ($5.0m) ($7.7m)
Net Cash Provided by (Used in) Financing Activities $730k $39.9m $346.7m $84.1m $227.1m $5.9m $2.5m $1.5m $12.3m $33.0m
Net increase (decrease) in cash and cash equivalents — ($10.4m) $26.5m ($25.0m) $67.1m $8.2m $245k ($14.8m) $75.6m ($18.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — $45.7m $72.2m $47.1m $114.2m $122.5m $122.7m $108.0m $183.6m $165.6m
Cash, Cash Equivalents, and Short-term Investments — — $307.3m $233.4m $323.5m $182.2m $190.6m $206.4m $243.6m $414.1m
Cash and cash equivalents at beginning of period — $45.7m $72.2m $47.1m $114.2m $122.5m $122.7m $108.0m $183.6m $165.6m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported — — — — — — $245k ($14.8m) $75.6m ($18.0m)
Income Taxes Paid, Net — $290k $383k $1.7m $482k $1.3m $10.7m $5.6m $2.0m $3.0m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.